Catalent Pharma Solutions Makes Major RTW Indiana Investment

Catalent Pharma Solutions is making a major investment soon in Right to Work Bloomington, Indiana. In fact, they plan to invest a total of $350 million toward an expansion. As a result, this will create over 2,300 new jobs. So this is some really exciting economic news!

From Area Development Magazine:

“Our continued growth in Bloomington demonstrates how important this site has become to the production of medicines for patients worldwide. [“¦] We are immensely grateful for our close collaboration with the state of Indiana, the city of Bloomington, and state and local economic development organizations. The talented, diverse Hoosier workforce and the ambitious business environment provide a strong foundation for our long-term presence in Bloomington.” [“¦]

“Indiana’s vibrant and unique life sciences industry continues to make a tremendous impact on the Hoosier state through its economic strength, contributing more than $79 billion in 2021. [“¦] Indiana is making strategic investments in those businesses, like Catalent, to advance smart technologies and processes, and that investment has allowed Indiana to become the second largest exporter of life sciences products in the U.S. and is recognized as a world leader in the industry.”

AREA DEVELOPMENT MAGAZINE

To read the previous Area Development update on Right to Work states, click here.

To read more updates on Right to Work states, click here.